Anna Licata
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 42
- Hepatitis C virus research 20
- Liver Disease and Transplantation 15
- Epidemiology 36
- Liver Disease Diagnosis and Treatment 21
- Hepatitis B Virus Studies 5
- Co-authors
- Antonio Craxı̀ (47 shared papers)Calogero Cammà (30 shared papers)Salvatore Petta (19 shared papers)V. Di Marco (17 shared papers)Daniela Cabibi (14 shared papers)Giulio Marchesini (10 shared papers)Fabio Salvatore Macaluso (5 shared papers)Giuseppe Licata (19 shared papers)
- Journals
- Digestive and Liver Disease (9 papers)Journal of Hepatology (7 papers)Internal and Emergency Medicine (6 papers)Alimentary Pharmacology & Therapeutics (5 papers)PLoS ONE (3 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Anna Licata
152 papers receiving 4.0k citations
Anna Licata's Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 1.3k
- Epidemiology 1.4k
- Pharmacology 268
- Orthopedics and Sports Medicine 212
- Nephrology 127
Countries citing papers authored by Anna Licata
This map shows the geographic impact of Anna Licata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Licata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Licata more than expected).
Fields of papers citing papers by Anna Licata
This network shows the impact of papers produced by Anna Licata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Licata. The network helps show where Anna Licata may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Licata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients Hit paper breakdown → | 2014 | 362 |
| 2 | 2015 | 185 | |
| 3 | 2016 | 183 | |
| 4 | 2017 | 158 | |
| 5 | 2008 | 146 | |
| 6 | 2011 | 108 | |
| 7 | 2006 | 83 | |
| 8 | 2004 | 82 | |
| 9 | 2017 | 80 | |
| 10 | 2003 | 79 | |
| 11 | 2016 | 72 | |
| 12 | 2017 | 71 | |
| 13 | 2013 | 69 | |
| 14 | 2016 | 65 | |
| 15 | 2008 | 63 | |
| 16 | 2015 | 63 | |
| 17 | 2003 | 63 | |
| 18 | 2018 | 60 | |
| 19 | 2006 | 59 | |
| 20 | 2018 | 59 |
About Anna Licata
Anna Licata is a scholar working on Hepatology, Epidemiology, Oncology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 158 papers that have together received 4.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (20 papers), Drug-Induced Hepatotoxicity and Protection (16 papers), Liver Disease and Transplantation (15 papers), Bone health and osteoporosis research (11 papers), Bone health and treatments (11 papers), Parathyroid Disorders and Treatments (9 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Hepatology (1.3k citations), Epidemiology (1.4k citations), Pharmacology (268 citations), Orthopedics and Sports Medicine (212 citations) and Nephrology (127 citations). Anna Licata has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Antonio Craxı̀, Calogero Cammà, Salvatore Petta, V. Di Marco, Daniela Cabibi, Giulio Marchesini, Fabio Salvatore Macaluso, Giuseppe Licata, Lydia Giannitrapani and Maurizio Soresi. Their work appears in journals such as Digestive and Liver Disease, Journal of Hepatology, Internal and Emergency Medicine, Alimentary Pharmacology & Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.